{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T10:01:30Z","timestamp":1704189690203},"reference-count":14,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3960\/jslrt.48.47","type":"journal-article","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T05:58:57Z","timestamp":1227765537000},"page":"47-54","source":"Crossref","is-referenced-by-count":5,"title":["t(11;18)(q21;q21)-positive Advanced-stage MALT Lymphoma Associated with Monoclonal Gammopathy : Resistance to Rituximab or Rituximab-containing Chemotherapy"],"prefix":"10.3960","volume":"48","author":[{"given":"Hitoshi","family":"Ohno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Economopoulos T, Papageorgiou S, Pappa V, Papageorgiou E, Valsami S, Kalantzis D, Xiros N, Dervenoulas J, Raptis S : Monoclonal gammopathies in B-cell non-Hodgkin's lymphomas. Leuk Res 27 : 505-508, 2003","DOI":"10.1016\/S0145-2126(02)00277-1"},{"key":"2","unstructured":"2 Isaacson PG, Muller-Hermelink HK, Piris MA, Berger F, Nathwani B, Swerdlow S, Harris NL : Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma), in Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) : World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2001, pp.157-160"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Asatiani E, Cohen P, Ozdemirli M, Kessler CM, Mavromatis B, Cheson BD : Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement. Am J Hematol 77 : 144-146, 2004","DOI":"10.1002\/ajh.20157"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Wohrer S, Streubel B, Bartsch R, Chott A, Raderer M : Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res 10 : 7179-7181, 2004","DOI":"10.1158\/1078-0432.CCR-04-0803"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Valdez R, Finn WG, Ross CW, Singleton TP, Tworek JA, Schnitzer B : Waldenstr&ouml;m macroglobulinemia caused by extranodal marginal zone B-cell lymphoma : a report of six cases. Am J Clin Pathol 116 : 683-690, 2001","DOI":"10.1309\/6WPX-66CM-KGRH-V4RW"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Berger F, Traverse-Glehen A, Felman P, Callet-Bauchu E, Baseggio L, Gazzo S, Thieblemont C, Ffrench M, Magaud JP, Salles G, Coiffer B : Clinicopathologic features of Waldenstr&ouml;m's macroglobulinemia and marginal zone lymphoma : are they distinct or the same entity? Clin Lymphoma 5 : 220-224, 2005","DOI":"10.3816\/CLM.2005.n.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Hirase N, Yufu Y, Abe Y, Muta K, Shiokawa S, Nawata H, Nishimura J : Primary macroglobulinemia with t(11;18)(q21;q21). Cancer Genet Cytogenet 117 : 113-117, 2000","DOI":"10.1016\/S0165-4608(99)00156-9"},{"issue":"11","key":"8","first-page":"1183","volume":"41","author":"IWASE SATSUKI","year":"2000","ISSN":"http:\/\/id.crossref.org\/issn\/0485-1439","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kunisaki Y, Muta T, Yamano Y, Kobayashi Y : Detection of two cell populations corresponding to distinct maturation stages in API-2\/MLT-positive mucosa-associated lymphoid tissue lymphoma cells proliferating in pleural effusion. Int J Hematol 78 : 357-361, 2003","DOI":"10.1007\/BF02983562"},{"key":"10","unstructured":"10 Mehta KU, Ghorab Z, DeVoto E : Waldenstr&ouml;m macroglobulinemia caused by extranodal marginal zone B-cell lymphoma. Am J Clin Pathol 117 : 495-496, 2002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Coiffier B : Rituximab therapy in malignant lymphoma. Oncogene 26 : 3603-3613, 2007","DOI":"10.1038\/sj.onc.1210376"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Raderer M, Jager G, Brugger S, Puspok A, Fiebiger W, Drach J, Wotherspoon A, Chott A : Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology 65 : 306-310, 2003","DOI":"10.1159\/000074641"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.128"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F, Ponzoni M, Pedrinis E, Dell'Oro S, Pruneri G, Filipazzi V, Dietrich PY, Gianni AM, Coiffier B, Cavalli F, Zucca E : Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102 : 2741-2745, 2003","DOI":"10.1182\/blood-2002-11-3496"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:45:39Z","timestamp":1621539939000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jslrt\/48\/2\/48_2_47\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.48.47","relation":{},"ISSN":["1880-9952","1346-4280"],"issn-type":[{"value":"1880-9952","type":"electronic"},{"value":"1346-4280","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}